<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Malaria in pregnancy: Epidemiology, clinical manifestations, diagnosis, and outcome</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Malaria in pregnancy: Epidemiology, clinical manifestations, diagnosis, and outcome</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Malaria in pregnancy: Epidemiology, clinical manifestations, diagnosis, and outcome</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Blair J Wylie, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen J Rogerson, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Johanna Daily, MD, MSc</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles J Lockwood, MD, MHCM</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 25, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Malaria infection in pregnancy is a major cause of maternal death, maternal anemia, and adverse pregnancy outcome (spontaneous abortion, preterm delivery, growth restriction/low birth weight, stillbirth, congenital infection, neonatal mortality) in geographic areas where malaria infection occurs commonly in pregnant women [<a href="#rid1">1</a>]. Pregnancy increases the chances of developing malaria infection and severe disease when infected. Pregnant women are particularly vulnerable to <em>Plasmodium falciparum</em> infection because red cells infected with the parasite can sequester in the placenta, and thereby cause adverse fetal effects. If anti-malarial drugs do not achieve therapeutic levels in the placenta, parasites sequestered there may be released intermittently into the peripheral blood and cause recurrent maternal infection [<a href="#rid2">2</a>].</p><p>Issues related to the epidemiology, clinical manifestations, diagnosis, and outcome of malaria in pregnancy will be reviewed here. Issues related to prevention and treatment of malaria in pregnancy are discussed separately. (See  <a class="medical medical_review" href="/d/html/4812.html" rel="external">"Malaria in pregnancy: Prevention and treatment"</a> and  <a class="medical medical_review" href="/d/html/5667.html" rel="external">"Treatment of severe malaria", section on 'Pregnancy'</a>.)</p><p>General issues related to malaria are also discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5702.html" rel="external">"Malaria: Epidemiology, prevention, and control"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5707.html" rel="external">"Laboratory tools for diagnosis of malaria"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5722.html" rel="external">"Prevention of malaria infection in travelers"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5704.html" rel="external">"Treatment of uncomplicated falciparum malaria in nonpregnant adults and children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5706.html" rel="external">"Non-falciparum malaria: P. vivax, P. ovale, and P. malariae"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/112633.html" rel="external">"Non-falciparum malaria: Plasmodium knowlesi"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Malaria occurs in most tropical countries [<a href="#rid3">3</a>]. Epidemiology within a region may vary considerably depending on location (eg, rural versus city), season (rainy versus dry), human migration patterns, and use of malaria prevention strategies. The risk of locally acquired malaria is extremely low in the United States, but rare cases were identified in 2023 [<a href="#rid4">4</a>].  (See  <a class="medical medical_review" href="/d/html/5702.html" rel="external">"Malaria: Epidemiology, prevention, and control"</a>.) </p><p>In general, for women living in a given geographic area, a higher prevalence of malaria has been observed among pregnant women than nonpregnant women, younger pregnant women than older pregnant women, women in their first or second pregnancies than in more multigravid women, human immunodeficiency virus (HIV)-infected women than women without HIV infection, and women in the first and second trimesters than women in the third trimester [<a href="#rid5">5-8</a>]. </p><p>The increased prevalence of malaria in pregnant women has been attributed to multiple factors, including increased susceptibility to mosquito bites [<a href="#rid9">9,10</a>], immunologic and hormonal changes related to pregnancy, and the ability of infected erythrocytes to adhere to and sequester in the intervillous space (ie, the vascular space filled with maternal blood on the maternal side of the placenta) [<a href="#rid11">11,12</a>] (see <a class="local">'Pathogenesis'</a> below). The increased risk for acquiring malaria and developing more severe disease persists for at least 60 to 70 days postpartum [<a href="#rid13">13,14</a>]. </p><p>In sub-Saharan Africa (a high transmission region), the median prevalence of maternal malaria (defined as peripheral or placental infection identified by microscopy) is 28 percent [<a href="#rid5">5</a>]. The prevalence can be even higher when more sensitive diagnostic methods (such as placental histology or polymerase chain reaction) are used [<a href="#rid5">5,15</a>]. In low transmission regions such as Asia and Latin America, the reported median prevalence of maternal malaria was 6.2 percent in 2007 [<a href="#rid5">5</a>]; however, malaria transmission is declining in these regions, so current prevalence may be lower.</p><p class="headingAnchor" id="H2238201536"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Species of malaria in humans include <em>P. falciparum</em>, <em>P. vivax</em>, <em>P. ovale</em>, <em>P. malariae,</em> and <em>P. knowlesi</em>. The effect of malaria on pregnancy varies by species and correlates with the ability of infected erythrocytes to adhere to and sequester in the placenta. (See <a class="local">'Pathogenesis'</a> below.) </p><p class="bulletIndent1"><span class="glyph">●</span><em>P. falciparum </em>invades red cells of all ages; it is associated with especially high levels of parasitemia, placental sequestration, and severe adverse maternal-fetal sequelae. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>P. vivax</em> is infrequently associated with placental sequestration and less commonly associated with severe adverse maternal and fetal outcomes [<a href="#rid16">16-19</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>P. knowlesi</em> is relatively rare in pregnancy, but severe disease in pregnant women has been described in Southeast Asia [<a href="#rid20">20</a>]. No placental changes have been observed in association with <em>P. knowlesi </em>infection [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>P. ovale</em> and <em>P. malariae</em> are not typically associated with severe illness in pregnancy. No placental changes have been observed in association with <em>P. ovale or P. malariae</em> infection [<a href="#rid11">11</a>].</p><p></p><p>Coinfection with multiple species is relatively uncommon and varies in prevalence with transmission intensity; it is most frequently observed with <em>P. falciparum </em>and <em>P. vivax</em> [<a href="#rid21">21</a>]. Sequential infection with the same or different species occurs more commonly than coinfection. </p><p>Issues related to non-falciparum malaria species are discussed further separately. (See  <a class="medical medical_review" href="/d/html/5706.html" rel="external">"Non-falciparum malaria: P. vivax, P. ovale, and P. malariae"</a>.) </p><p class="headingAnchor" id="H1635916535"><span class="h1">PATHOLOGY</span></p><p class="headingAnchor" id="H2760399790"><span class="h2">Placental infection</span><span class="headingEndMark"> — </span>Parasites may be absent in the peripheral blood but present in the placenta. In one study of 415 patients in Tanzania with histologic evidence of active placental malaria infection, parasitemia was absent in 46 percent of cases [<a href="#rid22">22</a>]. </p><p>In endemic settings, placental histology is largely a research tool, as it is only performed after delivery and cannot guide pregnancy management. Histopathologic findings of the malaria-infected placenta include [<a href="#rid12">12</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Infected erythrocytes and increased numbers of maternal phagocytic cells, especially monocytes, in the intervillous space.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemozoin (malaria pigment) deposition in phagocytic leucocytes and within fibrin deposits in the intervillous space. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Trophozoite and schizont stages of the parasite.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Syncytial degradation and increased syncytial knotting; in rare cases, localized destruction of the villi [<a href="#rid23">23</a>].</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>The key finding of <em>P. falciparum</em> malaria in pregnant women is parasites in the erythrocytes sequestered in the intervillous space  (<a class="graphic graphic_picture graphicRef51415" href="/d/graphic/51415.html" rel="external">picture 1</a>) [<a href="#rid24">24</a>]. These infected erythrocytes are immunologically distinct from infected erythrocytes found in nonpregnant individuals: they express a specific class of variant surface antigen (pregnancy-associated malaria variant surface antigen [VSA-PAM]) that mediates adhesion of infected erythrocytes to chondroitin sulfate A (CSA) on the syncytiotrophoblast lining the intervillous space [<a href="#rid25">25,26</a>]. VAR2CSA, which is the product of the parasite gene <em>VAR2CSA</em>, appears to be the major VSA-PAM involved, but additional VSA-PAMs may also exist [<a href="#rid27">27-29</a>]. </p><p>Adherence of erythrocytes expressing VSA-PAMs to the surface of syncytiotrophoblast appears to stimulate an inflammatory response. This results in monocyte migration and release of humoral factors, such as tumor necrosis factor-alpha (TNF-alpha), into the intervillous circulation that may promote preterm labor [<a href="#rid30">30</a>]. The concentration of TNF-alpha in the intervillous circulation correlates with the density of <em>P. falciparum</em>-infected erythrocytes. Individuals who carry the TNF 2 polymorphism in the promoter region of the TNF-alpha gene have heightened TNF-alpha production in response to infection, which increases their risk of preterm delivery, severe infection, and cerebral malaria [<a href="#rid30">30</a>].</p><p>Other potential consequences of erythrocyte adherence include placental thickening and altered placental functions, including reduced nutrient transport and production of key hormones (eg, insulin-like growth factor 1) [<a href="#rid31">31,32</a>].<strong> </strong>Together, these placental changes may reduce uteroplacental blood flow [<a href="#rid33">33</a>]<strong> </strong>and, early in pregnancy, may impede villous growth and development [<a href="#rid34">34</a>]. The resulting reduction in the fetal supply of oxygen, nutrients, and growth factors can lead to fetal growth restriction and fetal demise [<a href="#rid33">33-41</a>]. </p><p>Antibodies formed in response to VSA-PAM (particularly anti-VAR2CSA) prevent adhesion of the infected erythrocyte to the placenta [<a href="#rid42">42,43</a>]. These antibodies are sex specific (ie, men from malaria-endemic areas do not develop VSA-PAM antibodies) and correlate directly with parity in holoendemic (high transmission) areas. Primigravid women in holoendemic areas have no or low VSA-PAM immunoglobulin G (IgG) levels despite lifelong <em>P. falciparum</em> exposure, and thus are more prone to complications of pregnancy-associated malaria (eg, low birth weight, preterm delivery, maternal anemia) compared with multigravid women in holoendemic areas, who have moderate-to-high VSA-PAM IgG levels. </p><p>By comparison, in mesoendemic (low transmission) areas and areas where malaria is promptly treated, multigravid women do not have moderate-to-high VSA-PAM IgG levels and remain at increased risk of complications of malaria in each pregnancy. As an example, when rates of malaria transmission, placental malaria, and peripheral parasitemia fell in Mozambique between 2003 and 2012, a parallel reduction occurred in levels of antimalarial IgG antibodies against both pregnancy-specific parasite lines (placental, or CSA-binding) and more general parasite lines [<a href="#rid44">44</a>]. As a result of this reduced immunity, pregnant women infected with malaria had a higher frequency of adverse pregnancy outcomes (lower maternal hemoglobin and newborn birth weight) than those with malaria in pregnancy prior to this period. </p><p>In contrast to the above discussion of <em>P. falciparum</em>, for women with <em>P. vivax, </em>a direct link between adverse outcome and placental changes and placental sequestration of infected erythrocytes has not been clearly demonstrated. </p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL FINDINGS</span></p><p class="headingAnchor" id="H3847801981"><span class="h2">General principles</span><span class="headingEndMark"> — </span>The clinical presentation of malaria in pregnant women depends primarily on the endemicity of the region. Infection with more than one malaria species does not substantially alter clinical presentation. (See <a class="local">'Epidemiology'</a> above.) </p><p class="bulletIndent1"><span class="glyph">●</span>For women in holoendemic areas (high transmission rates), most malaria infections in pregnancy are asymptomatic, but the mother is at risk for developing anemia [<a href="#rid45">45,46</a>]. Maternal anemia and placental parasitemia may lead to adverse pregnancy outcomes, particularly low birth weight (which may represent intrauterine growth restriction or preterm birth or both). (See <a class="local">'Pregnancy outcome'</a> below.)</p><p></p><p class="bulletIndent1">Primigravid women in holoendemic areas (who have no or low pregnancy-associated malaria variant surface antigen [VSA-PAM] IgG levels) are more prone to complications of pregnancy-associated malaria than multigravid women (who have moderate-to-high VSA-PAM IgG levels), as discussed above. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For women in mesoendemic areas (relatively low transmission rates) or for women returning to holoendemic areas after a prolonged absence, malaria infection is more likely to result in symptomatic illness and serious complications (eg, maternal anemia, adverse pregnancy outcome) than in women in holoendemic areas [<a href="#rid5">5</a>]. Gravidity tends not to be an important factor because of low immunity. (See <a class="local">'Pregnancy outcome'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For women in areas of unstable malaria transmission (where there is little acquired immunity), both symptomatic illness and serious complications (eg, maternal anemia, miscarriage, stillbirth, low birth weight) are common when infection occurs. Gravidity tends not to be an important factor because of low immunity. (See <a class="local">'Pregnancy outcome'</a> below.)</p><p></p><p>The clinical manifestations of malaria are nonspecific and variable. Virtually all nonimmune individuals experience fever. Other frequent symptoms include chills, sweats, headache, myalgias, fatigue, nausea, abdominal pain, vomiting, diarrhea, jaundice, and cough. Hypoglycemia is a common complication of severe malaria, although the usual signs (sweating, tachycardia, neurologic impairment) are difficult to distinguish from systemic symptoms due to severe malaria. Compared with nonpregnant women, pregnant women experience more severe disease, including more hypoglycemia and more respiratory complications (pulmonary edema, acute respiratory distress syndrome) [<a href="#rid47">47</a>]. For example, hypoglycemia occurs in 58 percent of pregnant women [<a href="#rid48">48</a>] versus approximately 8 percent of nonpregnant adults [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a>.)</p><p>There is a semiquantitative relationship between the degree of parasitemia and severity of disease. In general, parasitemia is more prevalent in pregnant compared with nonpregnant women [<a href="#rid35">35,50,51</a>], with increased risk as early as the first trimester [<a href="#rid52">52</a>]. As an example, in a longitudinal study including more than 270 Beninese women followed from the preconception period through delivery, the incidence of microscopic and submicroscopic <em>P. falciparum </em>infections was highest in the first trimester [<a href="#rid53">53</a>].</p><p>Anemia is a common complication of malaria in pregnancy; approximately 60 percent of pregnant women presenting with malaria infection are anemic [<a href="#rid54">54,55</a>], and anemia may be one of the few signs of the disease [<a href="#rid56">56</a>]. The anemia is generally normocytic and normochromic, with a striking absence of reticulocytes. Microcytosis and hypochromia may be present due to the very high frequency of thalassemia trait and/or iron deficiency. Infected red cells may be seen on the peripheral blood smear. However, anemia can be due to one or more other etiologies, including nutritional deficiency or intestinal parasites (especially hookworm infections) in malaria-endemic settings. In one review, 5 to 10 percent of pregnant African women developed severe anemia (hemoglobin &lt;7 to 8 g/dL), and one-quarter of these cases were attributed to malaria [<a href="#rid5">5</a>]. </p><p class="headingAnchor" id="H10"><span class="h2">Women with HIV infection</span><span class="headingEndMark"> — </span>Pregnant women with HIV infection are at increased risk for malaria acquisition, placental malaria, high parasite density, severe clinical disease, and maternal and neonatal mortality (relative to pregnant women without HIV infection) [<a href="#rid7">7,57-62</a>]. Among women with HIV infection, clinical outcomes for primigravid and multigravid women are comparable [<a href="#rid61">61</a>]. </p><p>Malaria infection in patients with HIV infection has been associated with CD4 cell decline relative to patients with HIV infection without malaria [<a href="#rid63">63</a>]. Malaria infection may be associated with a temporary increase in HIV viral load, which returns to baseline after antimalarial treatment; it is uncertain whether this increase in viral load may be associated with an increase in risk of perinatal HIV transmission [<a href="#rid7">7,62,64,65</a>]. For this reason, if viral load is used to monitor the response to antiretroviral therapy, testing should be delayed for approximately two months if the patient has had a recent malaria infection. </p><p class="headingAnchor" id="H983356215"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Malaria should be suspected in the setting of fever (temperature ≥37.5°C) and relevant epidemiologic exposure (residence in or travel to an area where malaria is endemic). </p><p>The approach to diagnosis of malaria in pregnant women is the same as the approach in nonpregnant patients. (See  <a class="medical medical_review" href="/d/html/5707.html" rel="external">"Laboratory tools for diagnosis of malaria"</a>.)</p><p>Low-density malaria infections that are detectable by polymerase chain reaction (PCR) but below the detection threshold of microscopy or rapid diagnostic tests (RDTs) can contribute to transmission. Submicroscopic infections can be common; in one study from Benin, the incidence of submicroscopic infection was almost double that of microscopic infections across all trimesters of pregnancy [<a href="#rid53">53</a>].</p><p>However, the clinical value of PCR to detect low-density malaria infection in pregnant women with negative microscopy or RDTs is uncertain, and there is insufficient evidence to warrant routine use of PCR for this purpose. PCR positive, microscopy negative infection detected in pregnant women was associated with poor infant outcomes in Benin [<a href="#rid66">66</a>]; however, this finding was not associated with poor outcomes in other regions such as Malawi [<a href="#rid67">67</a>], Ghana [<a href="#rid68">68</a>], or India [<a href="#rid69">69</a>]. </p><p>Chorionic villus sampling is not used for prenatal diagnosis of placental malaria and theoretically could contribute to vertical transmission.</p><p class="headingAnchor" id="H2405569014"><span class="h1">PREGNANCY OUTCOME</span></p><p class="headingAnchor" id="H3968140630"><span class="h2">Overview</span><span class="headingEndMark"> — </span>Adverse maternal and perinatal outcomes associated with <em>P. falciparum</em> or <em>P. vivax </em>malaria in pregnancy include [<a href="#rid35">35,54,70-81</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Miscarriage</p><p class="bulletIndent1"><span class="glyph">●</span>Preterm birth (&lt;37 weeks of gestation)</p><p class="bulletIndent1"><span class="glyph">●</span>Low birth weight (LBW; &lt;2500 g at birth)</p><p class="bulletIndent1"><span class="glyph">●</span>Fetal growth restriction</p><p class="bulletIndent1"><span class="glyph">●</span>Stillbirth (intrauterine fetal demise)</p><p class="bulletIndent1"><span class="glyph">●</span>Neonatal mortality</p><p class="bulletIndent1"><span class="glyph">●</span>Congenital malaria infection </p><p class="bulletIndent1"><span class="glyph">●</span>Maternal anemia</p><p class="bulletIndent1"><span class="glyph">●</span>Maternal mortality </p><p class="bulletIndent1"><span class="glyph">●</span>Hypertensive disease of pregnancy</p><p></p><p>These complications are not mutually independent (eg, preterm birth often results in LBW) and do not occur with similar frequency in all infected women. Nonimmune women and women in regions of unstable transmission (who generally lack protective antibodies) are at increased risk of these outcomes when they develop malaria [<a href="#rid5">5</a>]. </p><p>Women in areas with high stable transmission rates (who are likely to have developed protective antibodies) are less likely to experience adverse pregnancy outcomes when they develop malaria, although they remain at risk for anemia even if otherwise asymptomatic [<a href="#rid82">82</a>]. Within high transmission areas, young women and women of low parity are the subgroups most likely to experience an adverse pregnancy outcome because they are most likely to have absent or low protective antibody levels due to lower cumulative exposure to malaria over their lifetime and lower exposure to pregnancy-associated malaria variant surface antigens (VSA-PAMs) due to no or few previous pregnancies [<a href="#rid27">27,54,82-90</a>]. </p><p class="headingAnchor" id="H1611471823"><span class="h2">Fetal effects</span></p><p class="headingAnchor" id="H879597561"><span class="h3">Reduction in birth weight</span><span class="headingEndMark"> — </span>In pregnancies complicated by malaria, both fetal growth restriction (estimated fetal weight &lt;10<sup>th</sup> percentile for gestational age) and preterm birth (birth &lt;37 weeks of gestation) contribute to LBW (&lt;2500 g at birth) [<a href="#rid33">33,91-95</a>]. An increasing number of <em>P. falciparum</em> infections during a pregnancy increases the risk of LBW [<a href="#rid96">96</a>]. </p><p>In some settings, malaria has been associated with up to 70 percent of fetal growth restriction and up to 25 percent of neonates with LBW [<a href="#rid5">5</a>]. Reduction in fetal weight and preterm birth occur primarily in infants of primigravidas, who are more likely to have severe placental sequestration, heavier parasite loads, anemia, and low levels of antibodies formed in response to VSA-PAM compared with multigravidas [<a href="#rid27">27,35,46,50,97</a>]. (See <a class="local">'Pathogenesis'</a> above.)</p><p>Maternal undernutrition, which is common in regions where malaria is prevalent, also plays a role. The effects of malnutrition and malaria infection on LBW appear to be independent, not synergistic [<a href="#rid98">98</a>]. </p><p class="headingAnchor" id="H121498734"><span class="h3">Neurodevelopment</span><span class="headingEndMark"> — </span>There is emerging evidence that maternal malaria infection may affect neurodevelopment [<a href="#rid99">99-101</a>]. In one study including 493 pregnant women in Benin with malaria infection whose children were followed to six years of age, children whose mothers had placental malaria and/or high-density peripheral blood infection were particularly likely to have impaired processing, cognitive, and learning capabilities [<a href="#rid99">99</a>].</p><p class="headingAnchor" id="H3363688347"><span class="h3">Vertical transmission</span><span class="headingEndMark"> — </span>All species of malaria parasite can be transmitted in utero; congenital disease is most often associated with <em>P. falciparum </em>and <em>P. vivax</em>. Placental infection is a prerequisite for, but does not predict, congenital disease. Placental infection is more common than cord blood parasitemia, which is more common than detection of parasites in the infant's peripheral blood [<a href="#rid102">102</a>].</p><p>Among immune pregnant women, the likelihood of transplacental malaria transmission appears to be small (up to 1.5 percent of cases) [<a href="#rid103">103,104</a>]. Semi-immune and nonimmune pregnant women have a much higher likelihood of transplacental malaria transmission (7 to 10 percent) [<a href="#rid70">70,105,106</a>].</p><p>Pregnant women with overt symptoms of malaria during pregnancy have a 1 to 4 percent risk of vertical transmission [<a href="#rid107">107</a>]. The low incidence of congenital infection despite the high incidence of placental infection is likely secondary to passive immunization via transplacental acquisition of maternal antibody [<a href="#rid108">108</a>].</p><p>Clinical manifestations of congenital malaria in newborns and prognosis are discussed separately. (See  <a class="medical medical_review" href="/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children", section on 'Children versus adults'</a>.)</p><p class="headingAnchor" id="H3801628010"><span class="h3">Subsequent risk for malaria infection</span><span class="headingEndMark"> — </span>Malaria infection during pregnancy may increase the subsequent risk of malaria infection in young children. In a meta-analysis of 11 studies, the pooled adjusted odds ratio for clinically defined malaria in young children was 2.82 (95% CI 1.82-4.38) [<a href="#rid109">109</a>]. The potential immunologic or epidemiologic factors underlying this association are subjects of ongoing study.</p><p class="headingAnchor" id="H2028664313"><span class="h2">Maternal effects</span><span class="headingEndMark"> — </span>Malaria is a leading cause of maternal mortality in regions of unstable endemicity where there are periodic epidemics among nonimmune patients [<a href="#rid110">110</a>]. Younger maternal age has been associated with higher rates of anemia and poorer maternal and fetal outcome, in part because younger women are more likely to be primigravid and nonimmune or only partially immune [<a href="#rid6">6,54,111</a>]. Maternal death may be related to cerebral malaria, acidosis, organ failure (pulmonary, renal, hepatic), and/or severe anemia.</p><p>The following studies are examples of the impact of malaria on maternal mortality in two countries:</p><p class="bulletIndent1"><span class="glyph">●</span>A study performed in The Gambia estimated that, during the malaria season, maternal mortality increased by 168 percent and the proportion of deaths due to anemia increased threefold [<a href="#rid112">112</a>]. It was estimated that malaria accounted for up to 93 maternal deaths per 100,000 live births.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A review of pregnancy-related maternal deaths in an urban Mozambique setting identified 239 maternal deaths (320 maternal deaths/100,000 live births) [<a href="#rid73">73</a>]. In this series, 15.5 percent of the deaths were directly attributable to malaria, and 19.7 percent of the women who died were parasitemic with <em>P. falciparum</em>. Over one-third of the malaria-related deaths occurred in primigravid adolescents, primarily associated with severe anemia. Autopsies on 161 women showed that 44 (27.3 percent) had histologic evidence of splenic malarial infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent prospective autopsy study including all consecutive pregnancy-related deaths in a tertiary level referral hospital in Mozambique noted massive accumulation of <em>P. falciparum</em>-infected erythrocytes in the small capillaries of the central nervous system, in most visceral capillaries (heart, lung, kidney, uterus), as well as the intervillous space [<a href="#rid113">113</a>].</p><p></p><p class="headingAnchor" id="H3003688724"><span class="h1">PREVENTION AND TREATMENT</span><span class="headingEndMark"> — </span>Prevention and treatment of malaria in pregnancy and management of pregnancy are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/4812.html" rel="external">"Malaria in pregnancy: Prevention and treatment"</a>.)</p><p class="headingAnchor" id="H1299180303"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/113035.html" rel="external">"Society guideline links: Malaria"</a>.)</p><p class="headingAnchor" id="H22734572"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/85721.html" rel="external">"Patient education: Malaria (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H19"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Among women living in a geographic region, a higher prevalence of malaria has been observed among pregnant women than in nonpregnant women, younger pregnant women than older pregnant women, women in their first or second pregnancies than in more multigravid women, women with HIV infection than women without HIV infection, and women in the first and second trimesters than women in the third trimester. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The increased prevalence of malaria in pregnant women has been attributed to multiple factors, including increased susceptibility to mosquito bites, immunologic and hormonal changes related to pregnancy, and the ability of infected erythrocytes to adhere to and sequester in the intervillous space. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiology</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In <em>Plasmodium falciparum</em> malaria, the infected erythrocytes  (<a class="graphic graphic_picture graphicRef51415" href="/d/graphic/51415.html" rel="external">picture 1</a>) are immunologically distinct from infected erythrocytes found in nonpregnant individuals: they express a specific class of variant surface antigen (pregnancy-associated malaria variant surface antigen [VSA-PAM]) that mediates adhesion of infected erythrocytes to chondroitin sulfate A (CSA) on the syncytiotrophoblast lining the intervillous space. VAR2CSA, which is the product of the parasite gene <em>VAR2CSA</em>, appears to be the major VSA-PAM involved. Once parasites adhere to the surface of trophoblastic villi, they induce an inflammatory response that may promote preterm labor. Another consequence is placental thickening from the inflammation, which may reduce placental transport of oxygen and nutrients, leading to fetal growth restriction and, possibly, fetal demise. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Antibodies formed in response to VSA-PAM (particularly anti-VAR2CSA) prevent cytoadhesion of the infected erythrocyte to the placenta; thus, primigravid women in holoendemic areas (who have no or low VSA-PAM IgG levels despite lifelong <em>P. falciparum</em> exposure) are more prone to complications of pregnancy-associated malaria than multigravid women in holoendemic areas, who have moderate-to-high VSA-PAM IgG levels. By comparison, in mesoendemic (low transmission) areas and areas where malaria is promptly treated, multigravid women do not have moderate-to-high VSA-PAM IgG levels and remain at increased risk of complications of malaria in each pregnancy. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The clinical presentation varies according to the endemicity of the region. For women in holoendemic (high transmission) areas, most malaria infections in pregnancy are asymptomatic, but the mother is at risk for developing anemia. For women in mesoendemic (relatively low transmission) areas or for women returning to holoendemic areas after a prolonged absence, malaria infection is more likely to result in symptomatic, and potentially life-threatening, illness and serious complications (eg, maternal anemia, adverse pregnancy outcome) than it is in women in holoendemic areas. For women in areas of unstable malaria transmission (where there is little acquired immunity), both symptomatic illness and serious complications (eg, maternal anemia, miscarriage, stillbirth, low birth weight) are common when infection occurs. (See <a class="local">'Clinical findings'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Virtually all nonimmune individuals experience fever. Other frequent symptoms include chills, sweats, headache, myalgias, fatigue, nausea, abdominal pain, vomiting, diarrhea, jaundice, and cough, as well as symptoms of hypoglycemia. (See <a class="local">'Clinical findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Malaria should be suspected in the setting of fever (temperature ≥37.5°C) and relevant epidemiologic exposure (residence in or travel to an area where malaria is endemic). The approach to diagnosis of malaria in pregnant women is the same as the approach in nonpregnant patients. Peripheral blood smears are typically used for diagnosis but may be negative in women with placental malaria who are otherwise asymptomatic. (See <a class="local">'Diagnosis'</a> above and  <a class="medical medical_review" href="/d/html/5707.html" rel="external">"Laboratory tools for diagnosis of malaria"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy outcome</strong> – Adverse pregnancy outcomes associated with malaria include fetal growth restriction/small for gestational age infant, preterm birth, low birth weight, stillbirth and neonatal death, congenital malaria infection, and maternal mortality. (See <a class="local">'Pregnancy outcome'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Maternal Health Task Force. Malaria in pregnancy https://www.mhtf.org/topics/malaria-in-pregnancy/ (Accessed on June 11, 2018).</li><li><a class="nounderline abstract_t">Cohee LM, Kalilani-Phiri L, Mawindo P, et al. Parasite dynamics in the peripheral blood and the placenta during pregnancy-associated malaria infection. Malar J 2016; 15:483.</a></li><li class="breakAll">World Health Organization. World Malaria Report 2018 chttp://apps.who.int/iris/bitstream/handle/10665/275867/9789241565653-eng.pdf?ua=1 (Accessed on February 04, 2019).</li><li class="breakAll">Locally Acquired Malaria Cases Identified in the United States. Distributed via the CDC Health Alert Network June 26, 2023 https://emergency.cdc.gov/han/2023/han00494.asp (Accessed on January 24, 2024).</li><li><a class="nounderline abstract_t">Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93.</a></li><li><a class="nounderline abstract_t">Bouyou-Akotet MK, Ionete-Collard DE, Mabika-Manfoumbi M, et al. Prevalence of Plasmodium falciparum infection in pregnant women in Gabon. Malar J 2003; 2:18.</a></li><li><a class="nounderline abstract_t">ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 2004; 71:41.</a></li><li><a class="nounderline abstract_t">Pons-Duran C, Mombo-Ngoma G, Macete E, et al. Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials. PLoS Med 2022; 19:e1004084.</a></li><li><a class="nounderline abstract_t">Lindsay S, Ansell J, Selman C, et al. Effect of pregnancy on exposure to malaria mosquitoes. Lancet 2000; 355:1972.</a></li><li><a class="nounderline abstract_t">Ansell J, Hamilton KA, Pinder M, et al. Short-range attractiveness of pregnant women to Anopheles gambiae mosquitoes. Trans R Soc Trop Med Hyg 2002; 96:113.</a></li><li><a class="nounderline abstract_t">Rogerson SJ, Desai M, Mayor A, et al. Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect Dis 2018; 18:e107.</a></li><li><a class="nounderline abstract_t">Rogerson SJ, Hviid L, Duffy PE, et al. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis 2007; 7:105.</a></li><li><a class="nounderline abstract_t">Diagne N, Rogier C, Sokhna CS, et al. Increased susceptibility to malaria during the early postpartum period. N Engl J Med 2000; 343:598.</a></li><li><a class="nounderline abstract_t">Ramharter M, Grobusch MP, Kiessling G, et al. Clinical and parasitological characteristics of puerperal malaria. J Infect Dis 2005; 191:1005.</a></li><li><a class="nounderline abstract_t">Rogerson SJ, Mkundika P, Kanjala MK. Diagnosis of Plasmodium falciparum malaria at delivery: comparison of blood film preparation methods and of blood films with histology. J Clin Microbiol 2003; 41:1370.</a></li><li><a class="nounderline abstract_t">Nosten F, McGready R, Simpson JA, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999; 354:546.</a></li><li><a class="nounderline abstract_t">Poespoprodjo JR, Fobia W, Kenangalem E, et al. Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis 2008; 46:1374.</a></li><li><a class="nounderline abstract_t">Singh N, Shukla MM, Sharma VP. Epidemiology of malaria in pregnancy in central India. Bull World Health Organ 1999; 77:567.</a></li><li><a class="nounderline abstract_t">Bôtto-Menezes C, Silva Dos Santos MC, Lopes Simplício J, et al. Plasmodium vivax Malaria in Pregnant Women in the Brazilian Amazon and the Risk Factors Associated with Prematurity and Low Birth Weight: A Descriptive Study. PLoS One 2015; 10:e0144399.</a></li><li><a class="nounderline abstract_t">Barber BE, Bird E, Wilkes CS, et al. Plasmodium knowlesi malaria during pregnancy. J Infect Dis 2015; 211:1104.</a></li><li><a class="nounderline abstract_t">Rijken MJ, McGready R, Boel ME, et al. Malaria in pregnancy in the Asia-Pacific region. Lancet Infect Dis 2012; 12:75.</a></li><li><a class="nounderline abstract_t">Ismail MR, Ordi J, Menendez C, et al. Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol 2000; 31:85.</a></li><li><a class="nounderline abstract_t">Crocker IP, Tanner OM, Myers JE, et al. Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta. Placenta 2004; 25:273.</a></li><li><a class="nounderline abstract_t">McGready R, Davison BB, Stepniewska K, et al. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. Am J Trop Med Hyg 2004; 70:398.</a></li><li><a class="nounderline abstract_t">Salanti A, Staalsoe T, Lavstsen T, et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003; 49:179.</a></li><li><a class="nounderline abstract_t">Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996; 272:1502.</a></li><li><a class="nounderline abstract_t">Salanti A, Dahlbäck M, Turner L, et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 2004; 200:1197.</a></li><li><a class="nounderline abstract_t">Gamain B, Trimnell AR, Scheidig C, et al. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. J Infect Dis 2005; 191:1010.</a></li><li><a class="nounderline abstract_t">Ayres Pereira M, Mandel Clausen T, Pehrson C, et al. Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1. PLoS Pathog 2016; 12:e1005831.</a></li><li><a class="nounderline abstract_t">Aidoo M, McElroy PD, Kolczak MS, et al. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet Epidemiol 2001; 21:201.</a></li><li><a class="nounderline abstract_t">Boeuf P, Aitken EH, Chandrasiri U, et al. Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transport. PLoS Pathog 2013; 9:e1003153.</a></li><li><a class="nounderline abstract_t">Umbers AJ, Boeuf P, Clapham C, et al. Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation. J Infect Dis 2011; 203:561.</a></li><li><a class="nounderline abstract_t">Griffin JB, Lokomba V, Landis SH, et al. Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study. Malar J 2012; 11:319.</a></li><li><a class="nounderline abstract_t">Moeller SL, Nyengaard JR, Larsen LG, et al. Malaria in Early Pregnancy and the Development of the Placental Vasculature. J Infect Dis 2019; 220:1425.</a></li><li><a class="nounderline abstract_t">McGregor IA. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 1984; 33:517.</a></li><li><a class="nounderline abstract_t">Dorman EK, Shulman CE, Kingdom J, et al. Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria. Ultrasound Obstet Gynecol 2002; 19:165.</a></li><li><a class="nounderline abstract_t">Suguitan AL Jr, Cadigan TJ, Nguyen TA, et al. Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon. Am J Trop Med Hyg 2003; 69:574.</a></li><li><a class="nounderline abstract_t">Suguitan AL Jr, Leke RG, Fouda G, et al. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. J Infect Dis 2003; 188:1074.</a></li><li><a class="nounderline abstract_t">Fried M, Muga RO, Misore AO, Duffy PE. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol 1998; 160:2523.</a></li><li><a class="nounderline abstract_t">Fried M, Kurtis JD, Swihart B, et al. Systemic Inflammatory Response to Malaria During Pregnancy Is Associated With Pregnancy Loss and Preterm Delivery. Clin Infect Dis 2017; 65:1729.</a></li><li><a class="nounderline abstract_t">Dong S, Kurtis JD, Pond-Tor S, et al. CXC ligand 9 response to malaria during pregnancy is associated with low-birth-weight deliveries. Infect Immun 2012; 80:3034.</a></li><li><a class="nounderline abstract_t">Beeson JG, Rogerson SJ, Elliott SR, Duffy MF. Targets of protective antibodies to malaria during pregnancy. J Infect Dis 2005; 192:1647.</a></li><li><a class="nounderline abstract_t">Staalsoe T, Shulman CE, Bulmer JN, et al. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 2004; 363:283.</a></li><li><a class="nounderline abstract_t">Mayor A, Bardají A, Macete E, et al. Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy. N Engl J Med 2015; 373:1607.</a></li><li><a class="nounderline abstract_t">McGregor IA, Wilson ME, Billewicz WZ. Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg 1983; 77:232.</a></li><li><a class="nounderline abstract_t">Brabin BJ, Ginny M, Sapau J, et al. Consequences of maternal anaemia on outcome of pregnancy in a malaria endemic area in Papua New Guinea. Ann Trop Med Parasitol 1990; 84:11.</a></li><li><a class="nounderline abstract_t">Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans R Soc Trop Med Hyg 1990; 84 Suppl 2:1.</a></li><li><a class="nounderline abstract_t">Saeed BO, Atabani GS, Nawwaf A, et al. Hypoglycaemia in pregnant women with malaria. Trans R Soc Trop Med Hyg 1990; 84:349.</a></li><li><a class="nounderline abstract_t">White NJ. The treatment of malaria. N Engl J Med 1996; 335:800.</a></li><li><a class="nounderline abstract_t">Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983; 61:1005.</a></li><li><a class="nounderline abstract_t">Nosten F, ter Kuile F, Maelankirri L, et al. Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg 1991; 85:424.</a></li><li><a class="nounderline abstract_t">Accrombessi M, Yovo E, Fievet N, et al. Effects of Malaria in the First Trimester of Pregnancy on Poor Maternal and Birth Outcomes in Benin. Clin Infect Dis 2019; 69:1385.</a></li><li><a class="nounderline abstract_t">Hounkonnou CPA, Briand V, Fievet N, et al. Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin. Clin Infect Dis 2020; 71:166.</a></li><li><a class="nounderline abstract_t">Espinoza E, Hidalgo L, Chedraui P. The effect of malarial infection on maternal-fetal outcome in Ecuador. J Matern Fetal Neonatal Med 2005; 18:101.</a></li><li><a class="nounderline abstract_t">Assabri AM, Muharram AA. Malaria in pregnancy in Hodiedah, Republic of Yemen. East Mediterr Health J 2002; 8:245.</a></li><li><a class="nounderline abstract_t">Whitty CJ, Edmonds S, Mutabingwa TK. Malaria in pregnancy. BJOG 2005; 112:1189.</a></li><li><a class="nounderline abstract_t">Ticconi C, Mapfumo M, Dorrucci M, et al. Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr 2003; 34:289.</a></li><li><a class="nounderline abstract_t">Ayisi JG, van Eijk AM, ter Kuile FO, et al. The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya. AIDS 2003; 17:585.</a></li><li><a class="nounderline abstract_t">Steketee RW, Wirima JJ, Bloland PB, et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 1996; 55:42.</a></li><li><a class="nounderline abstract_t">Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004; 363:1860.</a></li><li><a class="nounderline abstract_t">Bloland PB, Wirima JJ, Steketee RW, et al. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS 1995; 9:721.</a></li><li><a class="nounderline abstract_t">Kublin JG, Patnaik P, Jere CS, et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005; 365:233.</a></li><li><a class="nounderline abstract_t">Mermin J, Lule JR, Ekwaru JP. Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr 2006; 41:129.</a></li><li><a class="nounderline abstract_t">Subramaniam K, Plank RM, Lin N, et al. Plasmodium falciparum Infection Does Not Affect Human Immunodeficiency Virus Viral Load in Coinfected Rwandan Adults. Open Forum Infect Dis 2014; 1:ofu066.</a></li><li><a class="nounderline abstract_t">Mwapasa V, Rogerson SJ, Molyneux ME, et al. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 2004; 18:1051.</a></li><li><a class="nounderline abstract_t">Cottrell G, Moussiliou A, Luty AJ, et al. Submicroscopic Plasmodium falciparum Infections Are Associated With Maternal Anemia, Premature Births, and Low Birth Weight. Clin Infect Dis 2015; 60:1481.</a></li><li><a class="nounderline abstract_t">Taylor SM, Madanitsa M, Thwai KL, et al. Minimal Impact by Antenatal Subpatent Plasmodium falciparum Infections on Delivery Outcomes in Malawian Women: A Cohort Study. J Infect Dis 2017; 216:296.</a></li><li><a class="nounderline abstract_t">Williams JE, Cairns M, Njie F, et al. The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections. Clin Infect Dis 2016; 62:837.</a></li><li><a class="nounderline abstract_t">Singh N, Bharti PK, Singh MP, et al. What is the burden of submicroscopic malaria in pregnancy in central India? Pathog Glob Health 2015; 109:30.</a></li><li><a class="nounderline abstract_t">Hulbert TV. Congenital malaria in the United States: report of a case and review. Clin Infect Dis 1992; 14:922.</a></li><li><a class="nounderline abstract_t">Singh N, Saxena A, Chand SK, et al. Studies on malaria during pregnancy in a tribal area of central India (Madhya Pradesh). Southeast Asian J Trop Med Public Health 1998; 29:10.</a></li><li><a class="nounderline abstract_t">Sholapurkar SL, Gupta AN, Mahajan RC. Clinical course of malaria in pregnancy--a prospective controlled study from India. Trans R Soc Trop Med Hyg 1988; 82:376.</a></li><li><a class="nounderline abstract_t">Granja AC, Machungo F, Gomes A, et al. Malaria-related maternal mortality in urban Mozambique. Ann Trop Med Parasitol 1998; 92:257.</a></li><li><a class="nounderline abstract_t">Carles G, Bousquet F, Raynal P, et al. [Pregnancy and malaria. Study of 143 cases in French Guyana]. J Gynecol Obstet Biol Reprod (Paris) 1998; 27:798.</a></li><li><a class="nounderline abstract_t">McGregor IA. Thoughts on malaria in pregnancy with consideration of some factors which influence remedial strategies. Parassitologia 1987; 29:153.</a></li><li><a class="nounderline abstract_t">Newman RD, Hailemariam A, Jimma D, et al. Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a nonepidemic year. J Infect Dis 2003; 187:1765.</a></li><li><a class="nounderline abstract_t">McGready R, Lee SJ, Wiladphaingern J, et al. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis 2012; 12:388.</a></li><li><a class="nounderline abstract_t">van Geertruyden JP, Thomas F, Erhart A, D'Alessandro U. The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 2004; 71:35.</a></li><li><a class="nounderline abstract_t">Kaushik A, Sharma VK, Sadhna, et al. Malarial placental infection and low birth weight babies. Mater Med Pol 1992; 24:109.</a></li><li><a class="nounderline abstract_t">Harrington WE, Moore KA, Min AM, et al. Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester. BMC Med 2021; 19:98.</a></li><li><a class="nounderline abstract_t">Moore KA, Simpson JA, Scoullar MJL, et al. Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis. Lancet Glob Health 2017; 5:e1101.</a></li><li><a class="nounderline abstract_t">Yimam Y, Nateghpour M, Mohebali M, Abbaszadeh Afshar MJ. A systematic review and meta-analysis of asymptomatic malaria infection in pregnant women in Sub-Saharan Africa: A challenge for malaria elimination efforts. PLoS One 2021; 16:e0248245.</a></li><li><a class="nounderline abstract_t">Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 2003; 97:30.</a></li><li><a class="nounderline abstract_t">Fried M, Duffy PE. Maternal malaria and parasite adhesion. J Mol Med (Berl) 1998; 76:162.</a></li><li><a class="nounderline abstract_t">Andrews KT, Lanzer M. Maternal malaria: Plasmodium falciparum sequestration in the placenta. Parasitol Res 2002; 88:715.</a></li><li><a class="nounderline abstract_t">Akingbade OA. Embryotoxic and growth-retarding effects of malaria on pregnant mice. J Reprod Med 1992; 37:273.</a></li><li><a class="nounderline abstract_t">Duffy PE, Fried M. Plasmodium falciparum adhesion in the placenta. Curr Opin Microbiol 2003; 6:371.</a></li><li><a class="nounderline abstract_t">Nathwani D, Currie PF, Douglas JG, et al. Plasmodium falciparum malaria in pregnancy: a review. Br J Obstet Gynaecol 1992; 99:118.</a></li><li><a class="nounderline abstract_t">Okoko BJ, Ota MO, Yamuah LK, et al. Influence of placental malaria infection on foetal outcome in the Gambia: twenty years after Ian Mcgregor. J Health Popul Nutr 2002; 20:4.</a></li><li><a class="nounderline abstract_t">Redd SC, Wirima JJ, Steketee RW, et al. Transplacental transmission of Plasmodium falciparum in rural Malawi. Am J Trop Med Hyg 1996; 55:57.</a></li><li><a class="nounderline abstract_t">Schmiegelow C, Minja D, Oesterholt M, et al. Malaria and fetal growth alterations in the 3(rd) trimester of pregnancy: a longitudinal ultrasound study. PLoS One 2013; 8:e53794.</a></li><li><a class="nounderline abstract_t">Rijken MJ, Papageorghiou AT, Thiptharakun S, et al. Ultrasound evidence of early fetal growth restriction after maternal malaria infection. PLoS One 2012; 7:e31411.</a></li><li><a class="nounderline abstract_t">Briand V, Saal J, Ghafari C, et al. Fetal Growth Restriction Is Associated With Malaria in Pregnancy: A Prospective Longitudinal Study in Benin. J Infect Dis 2016; 214:417.</a></li><li><a class="nounderline abstract_t">Rijken MJ, De Livera AM, Lee SJ, et al. Quantifying low birth weight, preterm birth and small-for-gestational-age effects of malaria in pregnancy: a population cohort study. PLoS One 2014; 9:e100247.</a></li><li><a class="nounderline abstract_t">Schmiegelow C, Matondo S, Minja DTR, et al. Plasmodium falciparum Infection Early in Pregnancy has Profound Consequences for Fetal Growth. J Infect Dis 2017; 216:1601.</a></li><li><a class="nounderline abstract_t">Kalilani L, Mofolo I, Chaponda M, et al. The effect of timing and frequency of Plasmodium falciparum infection during pregnancy on the risk of low birth weight and maternal anemia. Trans R Soc Trop Med Hyg 2010; 104:416.</a></li><li><a class="nounderline abstract_t">Tuikue Ndam NG, Fievet N, Bertin G, et al. Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates. J Infect Dis 2004; 190:2001.</a></li><li><a class="nounderline abstract_t">Cates JE, Unger HW, Briand V, et al. Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data. PLoS Med 2017; 14:e1002373.</a></li><li><a class="nounderline abstract_t">Garrison A, Boivin MJ, Fiévet N, et al. The Effects of Malaria in Pregnancy on Neurocognitive Development in Children at 1 and 6 Years of Age in Benin: A Prospective Mother-Child Cohort. Clin Infect Dis 2022; 74:766.</a></li><li><a class="nounderline abstract_t">Bangirana P, Conroy AL, Opoka RO, et al. Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial. Clin Infect Dis 2023; 76:600.</a></li><li><a class="nounderline abstract_t">Weckman AM, Conroy AL, Madanitsa M, et al. Neurocognitive outcomes in Malawian children exposed to malaria during pregnancy: An observational birth cohort study. PLoS Med 2021; 18:e1003701.</a></li><li><a class="nounderline abstract_t">Schwetz, J, Peel, M. Congenital malaria and placental infections among Negroes of Central Africa. Trans R Soc Trop Med Hyg 1934; 28:167.</a></li><li><a class="nounderline abstract_t">Bergström S, Fernandes A, Schwalbach J, et al. Materno-fetal transmission of pregnancy malaria: an immunoparasitological study on 202 parturients in Maputo. Gynecol Obstet Invest 1993; 35:103.</a></li><li><a class="nounderline abstract_t">Subramanian D, Moise KJ Jr, White AC Jr. Imported malaria in pregnancy: report of four cases and review of management. Clin Infect Dis 1992; 15:408.</a></li><li><a class="nounderline abstract_t">Darie H, Haba M. [Congenital malaria]. Med Trop (Mars) 1992; 52:175.</a></li><li><a class="nounderline abstract_t">Lee WW, Singh M, Tan CL. A recent case of congenital malaria in Singapore. Singapore Med J 1996; 37:541.</a></li><li><a class="nounderline abstract_t">COVELL G. Congenital malaria. Trop Dis Bull 1950; 47:1147.</a></li><li><a class="nounderline abstract_t">Dobbs KR, Dent AE. Plasmodium malaria and antimalarial antibodies in the first year of life. Parasitology 2016; 143:129.</a></li><li><a class="nounderline abstract_t">Park S, Nixon CE, Miller O, et al. Impact of Malaria in Pregnancy on Risk of Malaria in Young Children: Systematic Review and Meta-Analyses. J Infect Dis 2020; 222:538.</a></li><li><a class="nounderline abstract_t">Looareesuwan S, Phillips RE, White NJ, et al. Quinine and severe falciparum malaria in late pregnancy. Lancet 1985; 2:4.</a></li><li><a class="nounderline abstract_t">Dicko A, Mantel C, Thera MA, et al. Risk factors for malaria infection and anemia for pregnant women in the Sahel area of Bandiagara, Mali. Acta Trop 2003; 89:17.</a></li><li><a class="nounderline abstract_t">Anya SE. Seasonal variation in the risk and causes of maternal death in the Gambia: malaria appears to be an important factor. Am J Trop Med Hyg 2004; 70:510.</a></li><li><a class="nounderline abstract_t">Castillo P, Menéndez C, Mayor A, et al. Massive Plasmodium falciparum visceral sequestration: a cause of maternal death in Africa. Clin Microbiol Infect 2013; 19:1035.</a></li></ol></div><div id="topicVersionRevision">Topic 4795 Version 51.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.mhtf.org/topics/malaria-in-pregnancy/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Maternal Health Task Force. Malaria in pregnancy https://www.mhtf.org/topics/malaria-in-pregnancy/ (Accessed on June 11, 2018).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27653788" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Parasite dynamics in the peripheral blood and the placenta during pregnancy-associated malaria infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27653788" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Parasite dynamics in the peripheral blood and the placenta during pregnancy-associated malaria infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27653788" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Parasite dynamics in the peripheral blood and the placenta during pregnancy-associated malaria infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17251080" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Epidemiology and burden of malaria in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12919637" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prevalence of Plasmodium falciparum infection in pregnant women in Gabon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15331818" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36054101" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10859048" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Effect of pregnancy on exposure to malaria mosquitoes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12055794" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Short-range attractiveness of pregnant women to Anopheles gambiae mosquitoes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29396010" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17251081" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Malaria in pregnancy: pathogenesis and immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10965006" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Increased susceptibility to malaria during the early postpartum period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15717279" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clinical and parasitological characteristics of puerperal malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12682116" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Diagnosis of Plasmodium falciparum malaria at delivery: comparison of blood film preparation methods and of blood films with histology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10470698" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Effects of Plasmodium vivax malaria in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18419439" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10444880" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Epidemiology of malaria in pregnancy in central India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26675007" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Plasmodium vivax Malaria in Pregnant Women in the Brazilian Amazon and the Risk Factors Associated with Prematurity and Low Birth Weight: A Descriptive Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25301955" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Plasmodium knowlesi malaria during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22192132" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Malaria in pregnancy in the Asia-Pacific region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10665918" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Placental pathology in malaria: a histological, immunohistochemical, and quantitative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15028419" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15100454" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12823820" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8633247" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15520249" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15717280" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27556547" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11668577" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23408887" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transport.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21216864" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22963509" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30590576" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Malaria in Early Pregnancy and the Development of the Placental Vasculature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6383091" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Epidemiology, malaria and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11876809" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14740871" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14513430" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9498798" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29020221" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Systemic Inflammatory Response to Malaria During Pregnancy Is Associated With Pregnancy Loss and Preterm Delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22689822" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : CXC ligand 9 response to malaria during pregnancy is associated with low-birth-weight deliveries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16206081" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Targets of protective antibodies to malaria during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14751701" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26488692" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6346592" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2184786" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Consequences of maternal anaemia on outcome of pregnancy in a malaria endemic area in Papua New Guinea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2219249" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2260165" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Hypoglycaemia in pregnant women with malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8703186" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The treatment of malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6370484" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : An analysis of malaria in pregnancy in Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1836685" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Malaria during pregnancy in an area of unstable endemicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30561538" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Effects of Malaria in the First Trimester of Pregnancy on Poor Maternal and Birth Outcomes in Benin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32215629" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16203594" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The effect of malarial infection on maternal-fetal outcome in Ecuador.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15339111" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Malaria in pregnancy in Hodiedah, Republic of Yemen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16101595" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Malaria in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14600573" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12598779" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8702036" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15183624" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7546417" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15652606" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16340488" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Association between malaria and CD4 cell count decline among persons with HIV.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25734136" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Plasmodium falciparum Infection Does Not Affect Human Immunodeficiency Virus Viral Load in Coinfected Rwandan Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15096809" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25694651" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Submicroscopic Plasmodium falciparum Infections Are Associated With Maternal Anemia, Premature Births, and Low Birth Weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28658935" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Minimal Impact by Antenatal Subpatent Plasmodium falciparum Infections on Delivery Outcomes in Malawian Women: A Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26721833" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25627878" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : What is the burden of submicroscopic malaria in pregnancy in central India?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1576289" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Congenital malaria in the United States: report of a case and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9740260" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Studies on malaria during pregnancy in a tribal area of central India (Madhya Pradesh).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3068848" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Clinical course of malaria in pregnancy--a prospective controlled study from India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9713540" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Malaria-related maternal mortality in urban Mozambique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10021993" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : [Pregnancy and malaria. Study of 143 cases in French Guyana].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3334080" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Thoughts on malaria in pregnancy with consideration of some factors which influence remedial strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12751034" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a nonepidemic year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22169409" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15331817" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The contribution of malaria in pregnancy to perinatal mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1307763" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Malarial placental infection and low birth weight babies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33902567" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28967610" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33793584" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : A systematic review and meta-analysis of asymptomatic malaria infection in pregnant women in Sub-Saharan Africa: A challenge for malaria elimination efforts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12886801" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Importance and prevention of malaria in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9535549" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Maternal malaria and parasite adhesion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12122428" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Maternal malaria: Plasmodium falciparum sequestration in the placenta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1564714" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Embryotoxic and growth-retarding effects of malaria on pregnant mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12941407" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Plasmodium falciparum adhesion in the placenta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1554661" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Plasmodium falciparum malaria in pregnancy: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12022158" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Influence of placental malaria infection on foetal outcome in the Gambia: twenty years after Ian Mcgregor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8702038" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Transplacental transmission of Plasmodium falciparum in rural Malawi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23326508" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Malaria and fetal growth alterations in the 3(rd) trimester of pregnancy: a longitudinal ultrasound study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22347473" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Ultrasound evidence of early fetal growth restriction after maternal malaria infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27389349" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Fetal Growth Restriction Is Associated With Malaria in Pregnancy: A Prospective Longitudinal Study in Benin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24983755" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Quantifying low birth weight, preterm birth and small-for-gestational-age effects of malaria in pregnancy: a population cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29029247" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Plasmodium falciparum Infection Early in Pregnancy has Profound Consequences for Fetal Growth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20207387" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : The effect of timing and frequency of Plasmodium falciparum infection during pregnancy on the risk of low birth weight and maternal anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15529266" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28792500" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34297062" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : The Effects of Malaria in Pregnancy on Neurocognitive Development in Children at 1 and 6 Years of Age in Benin: A Prospective Mother-Child Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36219705" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34582452" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Neurocognitive outcomes in Malawian children exposed to malaria during pregnancy: An observational birth cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Congenital malaria and placental infections among Negroes of Central Africa</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8449440" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Materno-fetal transmission of pregnancy malaria: an immunoparasitological study on 202 parturients in Maputo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1520785" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Imported malaria in pregnancy: report of four cases and review of management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1406215" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : [Congenital malaria].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9046213" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : A recent case of congenital malaria in Singapore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14817831" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Congenital malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26743626" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Plasmodium malaria and antimalarial antibodies in the first year of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32219317" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Impact of Malaria in Pregnancy on Risk of Malaria in Young Children: Systematic Review and Meta-Analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2861481" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Quinine and severe falciparum malaria in late pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14636978" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Risk factors for malaria infection and anemia for pregnant women in the Sahel area of Bandiagara, Mali.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15155982" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Seasonal variation in the risk and causes of maternal death in the Gambia: malaria appears to be an important factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23137191" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Massive Plasmodium falciparum visceral sequestration: a cause of maternal death in Africa.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
